American Van Lines Named Official Mover of the Florida Panthers

American Van Lines, a nationally recognized leader in professional moving services, is proud to announce its new partnership as the official mover of the Florida Panthers of the National Hockey League (NHL). The Panthers, founded in 1993 by H. Wayne Huizenga, play their home games at Amerant Bank Arena in Sunrise, Florida. This partnership reflects […]

SCIENTURE Provides Commercial Update on ARBLI(TM), the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

(NASDAQ:SCNX), Company highlights accelerating access and revenue growth for ARBLI(TM) and confirms REZENOPY(TM) launch timeline, addressing a combined US annual losartan and naloxone market size of close to $385 million Outlines Q1 2026 outlook and reports significant balance sheet improvement last quarter COMMACK, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) — SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX),

NordProtect launches Scam Protection bundle to shield Americans from rising online fraud

LONDON, Feb. 03, 2026 (GLOBE NEWSWIRE) — In response to the rapidly increasing number of online fraud incidents, the identity theft protection service NordProtect today announced the launch of its new Scam Protection bundle, designed to enhance American users' defenses against digital crimes. “Unfortunately, online fraud and various scams have become a natural part of

Lawsuit ALERT: Investors who lost over $100,000 with agilon health, inc. (NYSE: AGL) with purchases between February and August 2025 should contact the Shareholders Foundation

The Shareholders Foundation, Inc. announces that a deadline is coming up in the lawsuit for certain investors in shares of agilon health, inc. (NYSE: AGL). Investors, who purchased shares of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025 in excess of $100,000 have certain options and there are short and

Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced executive leadership transitions to

Rigel Appoints Michael P. Miller to the Board of Directors

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. “Mike has a strong track record of commercial excellence, and we’re delighted to have him join

Slope and CellCarta Expand Collaboration with Lab Kit Inventory Portal Agreement

Leading Biospecimen Lifecycle Management Platform and Global CRO Formalize Collaboration Following Successful Pilot Slope, the only end-to-end, vendor-agnostic platform for managing biospecimens and lab kits, and CellCarta, a leading global contract research organization (CRO), today announced they have formalized their Kit Inventory Portal (KIP) collaboration. This follows a successful pilot program and positions Slope’s platform

Cetera Welcomes Veteran Commonwealth Advisor Neil Henning

Independent advisor joins Cetera for growth, marketing support and Commonwealth-like service Cetera has welcomed longtime independent financial advisor Neil Henning, who joins the firm after more than 23 years affiliated with Commonwealth Financial Network. Based in New Jersey and North Carolina, Henning and his Fortress Financial wealth management team oversee approximately $75 million in assets

SCIENTURE Provides Commercial Update on ARBLI(TM), the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

SCIENTURE Provides Commercial Update on ARBLI(TM), the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium GlobeNewswire February 03, 2026 Company highlights accelerating access and revenue growth for ARBLI(TM) and confirms REZENOPY(TM) launch timeline, addressing a combined US annual losartan and naloxone market size of close to $385 million Outlines Q1 2026 outlook and reports significant

NordProtect launches Scam Protection bundle to shield Americans from rising online fraud

NordProtect launches Scam Protection bundle to shield Americans from rising online fraud GlobeNewswire February 03, 2026 LONDON, Feb. 03, 2026 (GLOBE NEWSWIRE) — In response to the rapidly increasing number of online fraud incidents, the identity theft protection service NordProtect today announced the launch of its new Scam Protection bundle, designed to enhance American users'

Scroll to Top